2-(7'hydroxy-2'cis-heptenyl)-4-hydroxycyclopent-2-en-1-one | 71098-00-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-(7'hydroxy-2'cis-heptenyl)-4-hydroxycyclopent-2-en-1-one
• 英文别名: 4-hydroxy-2-[(Z)-7-hydroxyhept-2-enyl]cyclopent-2-en-1-one
• CAS: 71098-00-5
• 化学式: C₁₂H₁₈O₃
• 分子量: 210.273
• InChiKey: XHADOGNVBBOCEQ-RQOWECAXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• 16-Hydroxy-16-vinyl (or cyclopropyl)-prostan-1-ols and pharmaceutical compositions containing the same
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0013107A1

  公开（公告）日：1980-07-09

  There are disclosed novel 15-deoxy-16-hydroxy-16- substituted prostanoic acid analogs in which the C-1 carboxyl is replaced by a primary alcohol and carboxylic acid esters, carbonates and carbamates thereof, and which have utility as bronchodilators, as hypotensive agents, and as agents forthe control of excessive gastric secretion. The novel compounds are represented by the formula: wherein Q is a divalent cyclopentyl moiety selected from the group consisting of: wherein R/ is an alkyl (C3-C7) optionally substituted with one or more alkyl groups of one to three carbon atoms; R2 is selected from the group hydroxyl, alkoxyl, alkanoyloxy, a protecting group such as tetrahydropyran-2-yl-oxy, triloweralkylsilyloxy; or alkoxyalkoxy such as wherein R' is hydrogen or alkyl (C1-C4) and R" is alkyl (C1-C4); X is the divalent radical wherein R3 is selected from the group vinyl and cyclopropyl; Z is selected from the group -(CH2)4, cis and and W is selected from the group consisting of -(CH2)3 OH and wherein R4 is selected from the group alkyl (C,-C.); alkoxy (C1-C4); dialkylamino (C1-C4); phenyl and phenyl substituted with one or more substituents selected from the group consisting of hydrogen, hydroxyl, lower alkyl, lower alkoxy, loweralkylthia, fluoride or chloride, wherein lower alkyl is C1-C4; The formula above embraces the optical isomers, racemic or other mixtures of these isomers and the mirror images thereof

  公开了新型 15-脱氧-16-羟基-16-取代的前列酸类似物，其中 C-1 羧基被伯醇及其羧酸酯、碳酸酯和氨基甲酸酯取代，可用作支气管扩张剂、降压药和控制胃分泌过多的药物。这些新型化合物由式表示： 其中 Q 是二价环戊基，选自由以下组成的组： 其中 R/ 是任选被一个或多个一至三个碳原子的烷基取代的烷基（C3-C7）；R2 选自羟基、烷氧基、烷酰氧基、保护基团如四氢吡喃-2-基氧基、三烷基硅氧基；或烷氧基烷氧基，如 其中 R' 为氢或烷基（C1-C4），R" 为烷基（C1-C4）； X 为二价基 其中 R3 选自乙烯基和环丙基组； Z 选自-(CH2)4 组，顺式和逆式。 和 W 选自-( )3 OH 和-( )4-OH 所组成的组。 其中 R4 选自烷基（C,-C.）；烷氧基（C1-C4）；二烷基氨基（C1-C4）；苯基和被一个或多个取代基取代的苯基，取代基选自氢、羟基、低级烷基、低级烷氧基、低级烷硫基、氟化物或氯化物组成的组，其中低级烷基为 C1-C4； 上式包括这些异构体的光学异构体、外消旋体或其他混合物及其镜像。
• Novel cyclopentenone derivatives and methods for the preparation of the novel compounds
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0043479A1

  公开（公告）日：1982-01-13

  Cyclopentenone compounds of formula I useful as intermediates in the preparation of certain substituted prostan-1-ols: wherein Z is and both R groups are the same and are hydrogen or the group: wherein R2 is (C1-C4) alkyl and R3 is hydrogen or (C1-C4) alkyl, with the proviso that Z is not -(CH2)4- when R is hydrogen. Processes for their preparation: by rearranging a substituted 2,5-dihydrofuran derivative of the formula: or by etherification of both OH functions in formula I with a 2-alkoxypropene of the formula

  式 I 的环戊烯酮化合物，可用作制备某些取代的原烷-1-醇的中间体： 其中 Z 是 且两个 R 基团相同，均为氢或基团： 其中 R2 是（C1-C4）烷基，R3 是氢或（C1-C4）烷基，但当 R 是氢时，Z 不是-(CH2)4-。 其制备方法：通过重新排列式 2，5-二氢呋喃的取代衍生物： 或将式 I 中的两个羟基官能团与式 2-烷氧基丙烯进行醚化反应
• US4206151A
  申请人：——

  公开号：US4206151A

  公开（公告）日：1980-06-03
• US4250325A
  申请人：——

  公开号：US4250325A

  公开（公告）日：1981-02-10